Scientists test new drug duo against tough cancers linked to faulty genes
Disease control
Recruiting now
This is an early-stage study to find a safe and tolerable dose of two oral drugs, olaparib and ASTX727, when given together. It is for adults with advanced solid tumors that have specific mutations in genes like BRCA1, BRCA2, PALB2, ATM, or CHEK2. The main goals are to check for …
Phase: PHASE1 • Sponsor: Pamela Munster • Aim: Disease control
Last updated Mar 31, 2026 12:12 UTC